Mutagenic effects of ribavirin in vivo

This publication has 29 references indexed in Scilit:

• How does ribavirin improve interferon-α response rates in hepatitis C virus infection?
  Journal of Hepatology, 2005
• Antiviral action of ribavirin in chronic hepatitis C
  Gastroenterology, 2004
• Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
  New England Journal of Medicine, 2002
• Mechanism of action of ribavirin in the combination treatment of chronic HCV infection
  Hepatology, 2002
• Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
  Published by Elsevier ,2001
• Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
  New England Journal of Medicine, 1998
• Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
  Published by Elsevier ,1998
• Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C
  The Lancet, 1998
• Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study
  Journal of Hepatology, 1996
• Sindbis virus mutants resistant to mycophenolic acid and ribavirin
  Virology, 1987